Labcorp’s Bid for New Trial Denied in $384 Million Patent Infringement Case

In a legal development involving high stakes in intellectual property, clinical laboratory giant Labcorp has been denied a request for a new trial following a substantial $384.4 million patent infringement verdict against the company. The lawsuit centered on Labcorp’s utilization of a method for testing genetic disorders during pregnancy. U.S. District Judge Alan Albright presided over the case, affirming the original judgment against Labcorp. For more details on the case, see the full article on Law360.